These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 23100217)
1. β-blockers for COPD inpatients. Suissa S; Ernst P Thorax; 2012 Nov; 67(11):936-7. PubMed ID: 23100217 [No Abstract] [Full Text] [Related]
2. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension. Stefan MS; Rothberg MB; Priya A; Pekow PS; Au DH; Lindenauer PK Thorax; 2012 Nov; 67(11):977-84. PubMed ID: 22941975 [TBL] [Abstract][Full Text] [Related]
3. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease. Rutten FH Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509 [TBL] [Abstract][Full Text] [Related]
4. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF). Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803 [TBL] [Abstract][Full Text] [Related]
5. The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study. Liao KM; Lin TY; Huang YB; Kuo CC; Chen CY Int J Chron Obstruct Pulmon Dis; 2017; 12():2573-2581. PubMed ID: 28894360 [TBL] [Abstract][Full Text] [Related]
6. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276 [TBL] [Abstract][Full Text] [Related]
7. Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease. Wade C; Wells JM Expert Rev Respir Med; 2020 Jul; 14(7):671-678. PubMed ID: 32250198 [TBL] [Abstract][Full Text] [Related]
8. [Even in COPD beta blockers can be administered - but not all]. de Zeeuw J MMW Fortschr Med; 2015 Oct; 157(18):44. PubMed ID: 26985506 [No Abstract] [Full Text] [Related]
9. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies. Du Q; Sun Y; Ding N; Lu L; Chen Y PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000 [TBL] [Abstract][Full Text] [Related]
10. Impact of chronic obstructive pulmonary disease on in-hospital morbidity and mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Șerban RC; Hadadi L; Șuș I; Lakatos EK; Demjen Z; Scridon A Int J Cardiol; 2017 Sep; 243():437-442. PubMed ID: 28506549 [TBL] [Abstract][Full Text] [Related]
11. [Chronic obstructive pulmonary disease on inpatients with heart failure. GESAIC study results]. Recio-Iglesias J; Grau-Amorós J; Formiga F; Camafort-Babkowski M; Trullàs-Vila JC; Rodríguez A; Med Clin (Barc); 2010 Apr; 134(10):427-32. PubMed ID: 20149399 [TBL] [Abstract][Full Text] [Related]
12. β-blockers in COPD - yes, it's OK (with care). Bryant L J Prim Health Care; 2012 Jun; 4(2):165. PubMed ID: 22852168 [No Abstract] [Full Text] [Related]
13. Heartbeat: Heart failure and obstructive lung disease: are beta-blockers underused? Otto CM Heart; 2016 Dec; 102(23):1855-1856. PubMed ID: 27836944 [No Abstract] [Full Text] [Related]